Increased TIGIT expressing NK cells with dysfunctional phenotype in AML patients correlated with poor prognosis

G Liu, Q Zhang, J Yang, X Li, L Xian, W Li, T Lin… - Cancer Immunology …, 2022 - Springer
AML is the most common blood cancer in adults with a high relapse and an overall poor
survival rate. NK cells have been demonstrated to have the capacity to eradicate AML blast …

[HTML][HTML] NK cell expression of Tim-3: First impressions matter

EC So, A Khaladj-Ghom, Y Ji, J Amin, Y Song, E Burch… - Immunobiology, 2019 - Elsevier
Given the heightened interest in manipulation of co-signaling cascades for cancer
immunotherapy, we sought to determine how/whether tumors decorated with therapeutic …

Apoptotic cells activate NKT cells through T Cell Ig-Like Mucin-Like–1 resulting in airway hyperreactivity

HH Lee, EH Meyer, S Goya, M Pichavant… - The Journal of …, 2010 - journals.aai.org
T cell Ig-like mucin-like–1 (TIM-1) is an important asthma susceptibility gene, but the
immunological mechanisms by which TIM-1 functions remain uncertain. TIM-1 is also a …

An increased number of PD-1+ and Tim-3+ CD8+ T cells is involved in immune evasion in gastric cancer

S Takano, H Saito, M Ikeguchi - Surgery today, 2016 - Springer
Purpose Co-signaling molecules play an important role in T cells. This study was designed
to investigate PD-1 and Tim-3 expression on T cells and the relationships between PD-1 …

Dysregulated expression of Tim-3 and NKp30 receptors on NK cells of patients with chronic lymphocytic leukemia

L Hadadi, M Hafezi, AA Amirzargar… - Oncology research and …, 2019 - karger.com
Background: In this study, the expression pattern of NKp30 and T cell immunoglobulin and
mucin domain-containing molecule-3 (Tim-3), as candidates for activating and inhibitory …

Targeting Blockage of STAT3 in Hepatocellular Carcinoma Cells Augments NK Cell Functions via Reverse Hepatocellular Carcinoma–Induced Immune Suppression

X Sun, Q Sui, C Zhang, Z Tian, J Zhang - Molecular cancer therapeutics, 2013 - AACR
STAT3 is an important transcriptional factor for cell growth, differentiation, and apoptosis.
Although evidence suggests a positive role for STAT3 in cancer, the inhibitory effects of …

T‐cell immunoglobulin mucin‐3 expression in bladder urothelial carcinoma: clinicopathologic correlations and association with survival

M Yang, Q Yu, J Liu, W Fu, Y Cao, L Yu… - Journal of surgical …, 2015 - Wiley Online Library
Background T cell immunoglobulin mucin‐3 (Tim‐3) was initially recognized as a pivotal
immune checkpoint inhibitor that maintains immune homeostasis and tolerance. Recently …

The role of regulatory T cells in the control of natural killer cells: relevance during tumor progression

F Ghiringhelli, C Ménard, F Martin… - Immunological …, 2006 - Wiley Online Library
Tumor immunosurveillance relies on cognate immune effectors [lymphocytes and interferon‐
γ (IFN‐γ)] and innate immunity [natural killer (NK) cells, natural killer group 2, member D …

Impaired functional responses in follicular lymphoma CD8+TIM-3+ T lymphocytes following TCR engagement

P Gravelle, C Do, C Franchet, S Mueller… - …, 2016 - Taylor & Francis
Upregulation of T cell immunoglobulin-3 (TIM-3) has been associated with negative
regulation of the immune response in chronic infection and cancer, including lymphoma …

Tim-3, a negative regulator of anti-tumor immunity

AC Anderson - Current opinion in immunology, 2012 - Elsevier
T cell immunoglobulin-3 (Tim-3) was identified nearly 10 years ago as a negative regulator
of IFN-γ-secreting CD4+ T helper 1 and CD8+ T cytotoxic 1 cells. Tim-3 is now classed with …